glp-1 and gip dual agonist & Agonists | Obesity Diabetes Management | Harrison's updates (22nd Ed.) Free Comparison Chart: GLP-1 and
Description
These side effects can usually be reduced by initiating the medication at a low dose and titrating slowly
Records were initially screened at title and abstract level, and potentially eligible records were examined in full text with reasons for exclusion being recorded
Disadvantages, compared to sitagliptin, include an injectable dosage form and gastrointestinal side effects
doi:10.1016/j.neuroscience.2012.09.081 131
It is important to note that randomized trials typically involve a highly selective group of individuals who do not accurately reflect the general population with T2DM
A., Kemmeries, G., Holst, J
